The amount of private equity gastrointestinal groups grew to 68 percent last year and is projected to expand throughout 2022, according to a report jointly published by consulting firm Fraser Healthcare and pharma research firm Spherix Global Insights.
Private equity’s place in gastroenterology: 3 physicians’ viewpoints
